Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has shared an announcement.
Shanghai MicroPort MedBot (Group) Co., Ltd. has announced a board meeting scheduled for August 28, 2025, to review and approve the interim results for the first half of 2025. The meeting will also consider the payment of an interim dividend and address other business matters, which could impact the company’s financial strategies and shareholder returns.
The most recent analyst rating on (HK:2252) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, focusing on the medical technology industry. The company, along with its subsidiaries, is involved in the development and production of medical robotics and related technologies.
Average Trading Volume: 7,593,761
Technical Sentiment Signal: Buy
Current Market Cap: HK$23.43B
Find detailed analytics on 2252 stock on TipRanks’ Stock Analysis page.